微信公众号:蹊之美股生物医药 / CaesarBiotech
标的公司:KemPharm, Inc. (NASDAQ:KMPH)
昨日,KemPharm, Inc. (KMPH) 股价上涨约42.8%,因此前该公司宣布,美国食品和药物管理局(FDA)已经批准了AZSTARYS™ (曾用名:KP415)的新药申请 (NDA) ,治疗6岁及以上的注...查看全文
chuminhua2021-03-05 00:13
日前,KemPharm和Corium联合宣布,FDA已批准一日一次的口服胶囊Azstarys上市,用于治疗6岁以上的注意力缺陷多动障碍(ADHD,又名多动症)儿童患者。新闻稿指出,这是首款包含d-哌甲酯“前药”(prodrug)的ADHD疗法,它能够在起效迅速的同时,长时间维持疗效。$KemPharm(KMPH)$ $Corium Internatio...查看全文
$KemPharm(KMPH)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-23-004793 Act: 34 Size: 77 KB 网页链接
$KemPharm(KMPH)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-23-004784 Act: 34 Size: 211 KB 网页链接
$KemPharm(KMPH)$ PREC14A Preliminary proxy statements, contested solicitations Accession Number: 0001437749-23-004742 Act: 34 Size: 868 KB 网页链接
$KemPharm(KMPH)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001437749-23-004450 Act: 34 Size: 350 KB 网页链接
$KemPharm(KMPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-23-001701 Act: 34 Size: 237 KB 网页链接
$KemPharm(KMPH)$ 8-K Current report, item 8.01 Accession Number: 0001437749-23-001447 Act: 34 Size: 166 KB 网页链接
$KemPharm(KMPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-23-001059 Size: 4 KB 网页链接
$KemPharm(KMPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-23-001060 Size: 5 KB 网页链接
$KemPharm(KMPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-23-000919 Size: 5 KB 网页链接
$KemPharm(KMPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-23-000915 Size: 5 KB 网页链接